CC-3149

N/A

Report date: 2025/01/26 16:42:48
NME

Base Information

Drug NameCC-3149
Drug Alias NameCaMKK2 inhibitor (Bristol Myers Squibb)calcium/calmodulin dependent protein kinase kinase 2 inhibitor (Bristol Myers Squibb)CC-3149
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium/calmodulin-dependent protein kinase kinase 2 inhibitors
TargetsCalcium/calmodulin-dependent protein kinase kinase 2
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A